RIA
ICPT

Realta Investment Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Realta Investment Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-105
Closed -$11K – 1493
2019
Q4 		$11K Sell
105
-75
-42% -$6.71K ﹤0.01% 1115
2019
Q3 		$12K Sell
180
-1,237
-87% -$83.1K ﹤0.01% 1074
2019
Q2 		$112K Buy
1,417
+787
+125% +$70.4K 0.03% 470
2019
Q1 		$70K Buy
+630
New +$68.8K 0.03% 470

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Realta Investment Advisors's ICPT Position: Q1 2020 in Review

Realta Investment Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2020, closing a stake of 105 shares — an estimated $11K sold.

Realta Investment Advisors first reported a position in ICPT in Q1 2019 and held it in 4 quarters. The position peaked at $112K in Q2 2019. 188 funds tracked by Wall St. Rank hold ICPT as of Q1 2020.

  • Realta Investment Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Realta Investment Advisors sold 105 Intercept Pharmaceuticals, Inc. shares in Q1 2020, an estimated $11K.
  • Realta Investment Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2019 and held it in 4 quarters.
  • Realta Investment Advisors's Intercept Pharmaceuticals, Inc. position peaked at $112K in Q2 2019.
  • 188 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2020.

Based on Realta Investment Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.